Maternal snuff use and smoking and the risk of oral cleft malformations - A population-based cohort study

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Gunnerbeck, Anna ^a   Bonamy, Anna Karin Edstedt ^a,b   Wikström, Anna Karin ^b,c   Granath, Fredrik ^b   Wickström, Ronny ^a   Cnattingius, Sven ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NITROSAMINE;

ARTICLE; CLEFT LIP PALATE; COHORT ANALYSIS; CONTROLLED STUDY; DELIVERY; FEMALE; FETUS OUTCOME; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL SMOKING; NEWBORN PERIOD; PREGNANCY; PRENATAL PERIOD; SMOKELESS TOBACCO; SMOKING CESSATION; SWEDEN; TOBACCO DEPENDENCE; TOBACCO USE; CLEFT LIP; CLEFT PALATE; NEWBORN; RISK FACTOR; SMOKING;

CLEFT LIP; CLEFT PALATE; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; RISK FACTORS; SMOKING; TOBACCO, SMOKELESS;

EID: 84898614205     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084715     Document Type: Article

References (52)

1. Mossey PA, Little J, Munger RG, Dixon MJ, Shaw WC (2009) Cleft lip and palate. Lancet 374:1773-1785.
2. Khoury MJ, Gomez-Farias M, Mulinare J (1989) Does maternal cigarette smoking during pregnancy cause cleft lip (Pubitemid 19075858)
3. Little J, Cardy A, Munger RG (2004) Tobacco smoking and oral clefts: a metaanalysis. Bull World Health Organ 82:213-218. (Pubitemid 38524327)
4. Chung KC, Kowalski CP, Kim HM, Buchman SR (2000) Maternal cigarette smoking during pregnancy and the risk of having a child with cleft lip/palate. Plast Reconstr Surg 105:485-491. (Pubitemid 30110980)
5. Kallen K (1997) Maternal smoking and orofacial clefts. Cleft Palate Craniofac J 34:11-16. (Pubitemid 27044585)
6. Coleman T, Cooper S, Thornton JG, Grainge MJ, Watts K, et al. (2012) A randomized trial of nicotine-replacement therapy patches in pregnancy. N Engl J Med 366:808-818.
7. Dempsey DA, Benowitz NL (2001) Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Saf 24:277-322. (Pubitemid 32378515)
8. Osterdahl BG, Jansson C, Paccou A (2004) Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market. J Agric Food Chem 52:5085-5088.
9. Stepanov I, Knezevich A, Zhang L, Watson CH, Hatsukami DK, et al. (2012) Carcinogenic tobacco-specific N-nitrosamines in US cigarettes: three decades of remarkable neglect by the tobacco industry. Tob Control 21:44-48.
10. Richter P, Hodge K, Stanfill S, Zhang L, Watson C (2008) Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines. Nicotine Tob Res 10:1645-1652.
11. Foulds J, Ramstrom L, Burke M, Fagerstrom K (2003) Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 12:349-359. (Pubitemid 39452035)
12. Gartner CE, Hall WD, Vos T, Bertram MY, Wallace AL, et al. (2007) Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet 369:2010-2014. (Pubitemid 46899160)
13. Lambe M (2007) Swedish snus for tobacco harm reduction. Lancet 370:1206; author reply 1206-1207. (Pubitemid 47503295)
14. Holm H, Jarvis MJ, Russell MA, Feyerabend C (1992) Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology (Berl) 108:507-511.
15. Benowitz NL (1997) Systemic absorption and effects of nicotine from smokeless tobacco. Adv Dent Res 11:336-341.
16. Wikstrom AK, Cnattingius S, Galanti MR, Kieler H, Stephansson O (2010) Effect of Swedish snuff (snus) on preterm birth. BJOG 117:1005-1010.
17. Wikstrom AK, Cnattingius S, Stephansson O (2010) Maternal use of Swedish snuff (snus) and risk of stillbirth. Epidemiology 21:772-778.
18. Gunnerbeck A, Wikstrom AK, Bonamy AK, Wickstrom R, Cnattingius S (2011) Relationship of maternal snuff use and cigarette smoking with neonatal apnea. Pediatrics 128:503-509.
19. The Swedish Medical Birth Register-a summary of content and quality. Article no: 2003-112-3Article no: 2003-112-3. Available: http://www. socialstyrelsen. se/Lists/Artikelkatalog/Attachments/10655/2003-112-3-20031123. pdf. Accessed 2003.
20. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, et al. (2011) External review and validation of the Swedish national inpatient register. BMC Public Health 11:450.
21. Lindmark G, Cnattingius S (1991) The scientific basis of antenatal care. Report from a state-of-the-art conference. Acta Obstet Gynecol Scand 70:105-109.
22. Robert E, Kallen B, Harris J (1996) The epidemiology of orofacial clefts. 1. Some general epidemiological characteristics. J Craniofac Genet Dev Biol 16:234-241. (Pubitemid 26394673)
23. Cnattingius S (2004) The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res 6 Suppl 2:S125-140. (Pubitemid 38678838)
24. Murray JC (2002) Gene/environment causes of cleft lip and/or palate. Clin Genet 61:248-256. (Pubitemid 36372641)
25. Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130.
26. Slotkin TA (1998) Fetal nicotine or cocaine exposure: which one is worse? J Pharmacol Exp Ther 285:931-945. (Pubitemid 28277888)
27. Hafstrom O, Milerad J, Sandberg KL, Sundell HW (2005) Cardiorespiratory effects of nicotine exposure during development. Respir Physiol Neurobiol 149:325-341. (Pubitemid 41406230)
28. Zhao Z, Reece EA (2005) Nicotine-induced embryonic malformations mediated by apoptosis from increasing intracellular calcium and oxidative stress. Birth Defects Res B Dev Reprod Toxicol 74:383-391. (Pubitemid 41579581)
29. Baroni T, Bellucci C, Lilli C, Pezzetti F, Carinci F, et al. (2010) Human cleft lip and palate fibroblasts and normal nicotine-treated fibroblasts show altered in vitro expressions of genes related to molecular signaling pathways and extracellular matrix metabolism. J Cell Physiol 222:748-756.
30. Kang P, Svoboda KK (2003) Nicotine inhibits palatal fusion and modulates nicotinic receptors and the PI-3 kinase pathway in medial edge epithelia. Orthod Craniofac Res 6:129-142.
31. Saad AY, Gartner LP, Hiatt JL (1990) Teratogenic effects of nicotine on palate formation in mice. Biol Struct Morphog 3:31-35.
32. Christensen K, Olsen J, Norgaard-Pedersen B, Basso O, Stovring H, et al. (1999) Oral clefts, transforming growth factor alpha gene variants, and maternal smoking: a population-based case-control study in Denmark, 1991-1994. Am J Epidemiol 149:248-255. (Pubitemid 29053165)
33. Shaw GM, Wasserman CR, Lammer EJ, O'Malley CD, Murray JC, et al. (1996) Orofacial clefts, parental cigarette smoking, and transforming growth factoralpha gene variants. Am J Hum Genet 58:551-561. (Pubitemid 26062486)
34. Lammer EJ, Shaw GM, Iovannisci DM, Finnell RH (2005) Maternal smoking, genetic variation of glutathione s-transferases, and risk for orofacial clefts. Epidemiology 16:698-701. (Pubitemid 41233627)
35. Official Statistics Sweden: Pregnancies, Deliveries and Newborn Infants. Available: http://www.socialstyrelsen. se/Lists/Artikelkatalog/Attachments/ 19033/2013-3-27.pdf. Accessed 2013.
36. Hackshaw A, Rodeck C, Boniface S (2011) Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. Hum Reprod Update 17:589-604.
37. Ericson A, Kallen B, Westerholm P (1979) Cigarette smoking as an etiologic factor in cleft lip and palate. Am J Obstet Gynecol 135:348-351. (Pubitemid 9253638)
38. Zeiger JS, Beaty TH, Liang KY (2005) Oral clefts, maternal smoking, and TGFA: a meta-analysis of gene-environment interaction. Cleft Palate Craniofac J 42:58-63. (Pubitemid 40129737)
39. Wyszynski DF, Duffy DL, Beaty TH (1997) Maternal cigarette smoking and oral clefts: a meta-analysis. Cleft Palate Craniofac J 34:206-210. (Pubitemid 27220839)
40. Werler MM, Lammer EJ, Rosenberg L, Mitchell AA (1990) Maternal cigarette smoking during pregnancy in relation to oral clefts. Am J Epidemiol 132:926-932. (Pubitemid 20363671)
41. Khoury MJ, Weinstein A, Panny S, Holtzman NA, Lindsay PK, et al. (1987) Maternal cigarette smoking and oral clefts: a population-based study. Am J Public Health 77:623-625. (Pubitemid 17056058)
42. Meyer KA, Williams P, Hernandez-Diaz S, Cnattingius S (2004) Smoking and the risk of oral clefts: exploring the impact of study designs. Epidemiology 15:671-678. (Pubitemid 40416882)
43. Cnattingius S, Haglund B, Meirik O (1988) Cigarette smoking as risk factor for late fetal and early neonatal death. BMJ 297:258-261.
44. Brender JD, Olive JM, Felkner M, Suarez L, Marckwardt W, et al. (2004) Dietary nitrites and nitrates, nitrosatable drugs, and neural tube defects. Epidemiology 15:330-336. (Pubitemid 40416953)
45. Brender JD, Werler MM, Kelley KE, Vuong AM, Shinde MU, et al. (2011) Nitrosatable drug exposure during early pregnancy and neural tube defects in offspring: National Birth Defects Prevention Study. Am J Epidemiol 174:1286-1295.
46. Croen LA, Todoroff K, Shaw GM (2001) Maternal exposure to nitrate from drinking water and diet and risk for neural tube defects. Am J Epidemiol 153:325-331. (Pubitemid 32144557)
47. Huber JC, Jr., Brender JD, Zheng Q, Sharkey JR, Vuong AM, et al. (2013) Maternal dietary intake of nitrates, nitrites and nitrosamines and selected birth defects in offspring: a case-control study. Nutr J 12:34.
48. Morales-Suarez-Varela MM, Bille C, Christensen K, Olsen J (2006) Smoking habits, nicotine use, and congenital malformations. Obstet Gynecol 107:51-57.
49. George L, Granath F, Johansson AL, Cnattingius S (2006) Self-reported nicotine exposure and plasma levels of cotinine in early and late pregnancy. Acta Obstet Gynecol Scand 85:1331-1337.
50. Wehby GL, Murray JC (2010) Folic acid and orofacial clefts: a review of the evidence. Oral Dis 16:11-19.
51. Shaw GM, Lammer EJ (1999) Maternal periconceptional alcohol consumption and risk for orofacial clefts. J Pediatr 134:298-303. (Pubitemid 30417637)
52. Munger RG, Romitti PA, Daack-Hirsch S, Burns TL, Murray JC, et al. (1996) Maternal alcohol use and risk of orofacial cleft birth defects. Teratology 54:27-33. (Pubitemid 26395136)